Statement on Glucagen Hypokit supply 2 August 2023 Novo Nordisk has notified the Therapeutic Goods Administration that the Glucagen Hypokit is currently in a shortage that will last until 30 September 2023. The Glucagen Hypokit is used to treat severe hypoglycaemia where a person is unconscious or unable to take oral hypo treatments. If a person has a severe hypo and you don’t have a Hypokit you need to call 000 immediately. Diabetes Australia is working with the diabetes sector and the TGA to ensure people at highest risk are prioritized access to available supply. The TGA have also activated Section 19A provisions and is arranging imports of Hypokits from other countries. If you have concerns please talk to someone from your diabetes healthcare team.
Blog 2 February 2025 Diabetes-friendly guide to shedding those extra Christmas kilos Follow this diabetes-friendly guide to shedding those extra kilos and regaining control of your health. Continue Reading
News 29 January 2025 Urgent Product Correction Notification: Dexcom G6 receivers An Urgent Product Correction Notification has been issued for Dexcom G6 Continuous Glucose Monitoring (CGM) receivers. Manufacturer AMSL Diabetes says... Continue Reading
News 18 December 2024 Ozempic supply to remain limited in 2025 Ozempic supply will continue to be limited until the end of 2025, according to the latest advice from Novo Nordisk,... Continue Reading